Factors that influence stability of recombinant adenoviral preparations for human gene therapy

Pharmaceutical Development and Technology

Volumn 3, Issue 3, 1998, Pages 373-383

  Croyle, Maria A ^a,e   Roessler, Blake J ^a,b   Davidson, Beverly L ^c   Hilfinger, John M ^d   Amidon, Gordon L ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d TSRL INC   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adenovirus; Cryopreservation; Freeze drying; pH

Indexed keywords

CALCIUM CHLORIDE; GELATIN; GLYCINE; MANNITOL; SORBITOL; SUCROSE; TREHALOSE; VIRUS VACCINE;

ADENOVIRUS; ARTICLE; CONTROLLED STUDY; CRYOPRESERVATION; DRUG FORMULATION; DRUG STABILITY; GENE THERAPY; PRIORITY JOURNAL; VIRUS GENE; VIRUS RECOMBINANT;

EID: 0031663208     PISSN: 10837450     EISSN: None     Source Type: Journal    
DOI: 10.3109/10837459809009865     Document Type: Article

References (43)

1. J. F. Engelhardt, Y. Yang, L. D. Stratford-Perricaudet, E. D. Allen, K. Kozarsky, M. Perricaudet, J. R. Yankaskas, and J. M. Wilson, Direct gene transfer of human CFTR into human bronchial epithelia of xenografts with E1-deleted adenoviruses, Nat. Genet., 4, 27-34 (1993).
2. S.-J. Chen, J. M. Wilson, D. K. Vallance, J. W. Hartman, B. L. Davidson, and B. J. Roessler, A recombinant adenoviral vector expressing a soluble form of VCAM-1 inhibits VCAM-1/VLA-4 adhesion in transduced synoviocytes, Gene Ther., 2, 1-12 (1995).
3. B. L. Davidson, S. E. Doran, D. S. Shewach, J. M. Latta, J. W. Hartman, and B. J. Roessler, Expression of Escherichia coli β-galactosidase and Rat HPRT in the CNS of Macaca mulatta following adenoviral mediated gene transfer, Exp. Neurol., 121(2), 258-267 (1994).
4. R. J. C. Harris, The preservation of viruses, in Biological Applications of Freezing and Drying (R. J. C. Harris, ed.), Academic Press, New York, 1954, pp. 201-214.
5. T. Arkawa and S. N. Timasheff, Stabilization of protein structure by sugars, Biochemistry, 21(25), 6536-6545 (1982).
6. J. F. Back, D. Oakenfull, and M. B. Smith, Increased thermal stability of proteins in the presence of sugars and polyols, Biochemistry, 18(23), 5191-5196 (1979).
7. M. T. Townsend and P. P. DeLuca, Use of lyoprotectants in the freeze-drying of a model protein, ribonuclease A, J. Parenter. Sci. Technol., 42(6), 190-199 (1988).
8. C. L. Howell and M. J. Miller, Effect of sucrose phosphate and sorbitol on infectivity of enveloped viruses during storage, J. Clin. Microbiol., 18(3), 658-662 (1983).
9. G. O. Phillips, R. Harrop, D. J. Wedlock, H. Srbova, V. Celba, and M. Drevo, A study of water binding in lyophilized viral vaccine systems, Cryobiology, 18, 414-419 (1981).
10. P. S. Bennett, R. Z. Maigetter, M. G. Olson, P. J. Provost, E. M. Scattergood, and T. L. Scholfield, The effects of freeze-drying on the potency and stability of live varicella virus vaccine, Dev. Biol. Stand., 74, 215-221 (1990).
11. M. A. Croyle, B. L. Davidson, B. J. Roessler, and G. L. Amidon, Pharmaceutical stabilization of adenoviral vectors, Proc. Int. Symp. Controlled Release Bioact. Mater., 1, 1433-1434 (1994).
12. F. L. Graham, J. Smiley, W. C. Russell, and R. Nairn, Characteristics of a human cell line transformed by DNA from human adenovirus Type 5, J. Gen.Virol., 36, 59-74 (1977).
13. F. L. Graham and A. J. van der Eb, A new technique for the assay of infectivity of human adenovirus 5 DNA, Virology, 52, 456-467 (1973).
14. J. H. Miller, Experiments in Molecular Genetics, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1972, p. 48.
15. S. Nema and K. E. Avis, Freeze-thaw studies of a model protein, lactate dehydrogenase, in the presence of cryoprotectants, J. Parenter. Sci. Technol., 47(2), 76-83 (1993).
16. M. J. Pikal, Freeze-drying of proteins part 1: Process design, Biopharm, 1(3), 18-27 (1990).
17. F. Franks, Freeze-drying: From empiricism to predict-ability, Cryo-Lett., 11, 93-110 (1990).
18. M. J. Pikal, Freeze-drying of proteins part II: Formulation selection, Biopharm, 2(4), 26-30 (1990).
19. L. van den Berg and F. S. Soliman, Effect of glycerol and dimethyl sulfoxide on changes in composition and pH of buffer salt solutions during freezing, Cryobiology, 6(2), 93-97 (1969).
20. J. L. Cleland, M. F. Powell, and S. J. Shire, The development of stable protein formulations: A close look at protein aggregation, deamidation, and oxidation, Crit. Rev. Ther. Drug Carrier Syst., 10(4), 307-377 (1993).
21. B. M. Eckhardt, J. Q. Oeswein, and T. A. Bewley, Effect of freezing on aggregation of human growth hormone, Pharm. Res., 8(11), 1360-1364 (1991).
22. L. R. Rey, Glimpses into the fundamental aspects of freeze-drying, in Freeze-Drying of Biological Products, Developments in Biological Standardization (V. J. Cabasso and R. H. Regamey, eds.), S. Karger, Basel, 1977, pp. 19-27.
23. M. A. Croyle, D. J. Anderson, B. J. Roessler, and G. L. Amidon, Development of a highly efficient purification process for recombinant adenoviral vectors for oral gene delivery, Pharm. Dev. and Technol., 3(3), 365-372 (1998).
24. M. V. Nermut, Fine structure of adenovirus type 5, Virology, 65, 480-495 (1975).
25. Y. Chardonnet and S. Dales, Early events in the interaction of adenoviruses with HeLa cells. III. Relationship between an ATP-ase activity in nuclear envelopes and transfer of core material, Virology, 48, 342-359 (1972).
26. M. Cotten, E. Wagner, K. Zatloukal, S. Phillips, D. Curiel, and M. L. Birnstiel, High-efficiency receptor-mediated delivery of small and large (48 kilobase) gene constructs using the endosome-disruption activity of defective or chemically inactivated adenovirus particles, Proc. Natl. Acad. Sci. USA, 89, 6094-6098 (1992).
27. M. J. Taylor, The meaning of pH at low temperatures, Cryo-Lett., 2, 231-239 (1981).
28. F. S. Soliman and L. van den Berg, Factors affecting freezing damage of lactate dehydrogenase, Cryobiology, 8(1), 73-78 (1971).
29. T. Yamamoto, The effect of ion concentration and pH on the thermal stability of a canine adenovirus, Can. J. Microbiol., 13, 1139-1149 (1967).
30. L. D. Stratford-Perricaudet and M. Perricaudet, Gene therapy, the advent of adenovirus, in Gene Therapeutics, Methods and Applications of Direct Gene Transfer (J. A. Wolff, ed.), Birkhauser, Boston, MA, 1994, pp. 344-362.
31. P. L. Stewart, and R. M. Burnett, Adenovirus structure by X-ray crystallography and electron microscopy, in The Molecular Repertoire of Adenovirus I. Virion Structure and Infection (W. Doerfler and P. Bohm, eds.), Springer-Verlag, Berlin, 1995, pp. 25-38.
32. T. J. Wickham, E. J. Filardo, D. A. Cheresh, and G. R. Nemerow, Integrin alpha V beta 5 selectively promotes adenovirus mediated cell membrane permeabilization, J. Cell Biol., 127(1), 257-264 (1994).
33. N. Murase and F. Franks, Salt precipitation during the freeze-concentration of phosphate buffer solutions, Biophys. Chem., 34, 293-300 (1989).
34. R. A. Durst and B. R. Staples, Tris/Tris HCl: A standard buffer for use in the physiologic pH range, Clin. Chem., 18(3), 206-208 (1972).
35. J. Stanton, G. Taucher-Scholz, M. Schneider, J. Heilmann, and G. Kraft, Protection of DNA from high LET radiation by two OH radical scavengers, Tris (hydroxymethyl) aminomethane and 2-mercaptoethanol, Radiat. Environ. Biophys., 32(1), 21-32 (1993).
36. B. Chaillot, P. Labrude, C. Vignernon, and D. Simatos, Freeze-drying of hemoglobin solutions without adjuvant and in presence of glucose, Tris, and β-alanine: A study by electron spin resonance of the oxidized compounds produced, Am. J. Hematol., 10, 319-326 (1981).
37. D. Greiff, Stabilities of suspensions of influenza virus dried by sublimation of ice in vacuo to different contents of residual moisture and sealed under different gases, Appl. Microbiol., 20(6), 935-938 (1970).
38. S. W. Thompson, M. R. Allen, and M. E. McDowell, Toxicity studies with Tris (hydroxymethyl) aminomethane, Lab. Rep. No. 285., Rep. U.S. Army Med. Res. Nutr. Lab. Denver, July 1, 1-33 (1965).
39. H. Yasue, M. Nagao, S. Omote, A. Takizawa, K. Miwa, and S. Tanaka, Coronary arterial spasm and Prinzmetal's variant form of angina induced by hyperventilation and Tris-buffer infusion, Circulation, 58(1), 56-62 (1978).
40. A. Fisk and S. Pathak, HEPES-buffered medium for organ culture, Nature, 224(223), 1030-1031 (1969).
41. R. E. Kramer, N-2-hydroxyethylpiperazine-N′-2-ethanesulfonic acid (HEPES) does not modify the angiotensin II-stimulated calcium signal in cultured bovine glomerulosa cells, Life Sci., 48(1), 27-35 (1991).
42. C. J. Shipman, Evaluation of 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) as a tissue culture buffer, Proc. Soc. Exp. Biol. Med., 130(1), 305-310 (1969).
43. J. H. Crowe, J. F. Carpenter, L. M. Crowe, and T. J. Anchordoguy, Are freezing and dehydration similar stress vectors? A comparison of modes of interaction of stabilizing solutes with biomolecules, Cryobiology, 27, 219-231 (1990).